Alnylam Pharmaceuticals shares owned by T. Rowe Price Investment Management
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by T. Rowe Price Investment Management
from 13F filings
Historical chart of T. Rowe Price Investment Management investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by T. Rowe Price Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by T. Rowe Price Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $991M | 2.2M | 456.00 |
| 2025-06-30 | $1.4B | 4.3M | 326.09 |
| 2024-12-31 | $1.0B | 4.4M | 235.31 |
| 2024-09-30 | $863M | 3.1M | 275.03 |
| 2024-06-30 | $766M | 3.2M | 243.00 |
| 2024-03-31 | $429M | 2.9M | 149.45 |
| 2023-09-30 | $602M | 3.4M | 177.10 |
| 2023-06-30 | $615M | 3.2M | 189.94 |
| 2023-03-31 | $607M | 3.0M | 200.32 |
| 2022-12-31 | $761M | 3.2M | 237.65 |
More positions owned by T. Rowe Price Investment Management
View all positions for T. Rowe Price Investment Management